 |
|
Photo copyright Steven Foster
|
Common names: Cascara sagrada, Sacred bark
Botanical names: Cascara sagrada, Rhamnus
purshiani cortex
Parts used and where grown: Cascara is a small to medium-size
tree native to the provinces and states of the Pacific coast, including British Columbia,
Washington, Oregon, and northern California. The bark of the tree is removed, cut into small
pieces, and dried for one year before being used medicinally. Fresh cascara bark has an emetic
or vomit-inducing property and therefore is not used.
Cascara has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Historical or traditional use (may or may not
be supported by scientific studies): Northern California Indians introduced this
herb, which they called sacred bark, to 16th century Spanish explorers. As it is much milder
in its laxative action than the herb buckthorn, cascara became popular in Europe as a
treatment for constipation. Cascara has been an
approved treatment for constipation in the U.S. Pharmacopoeia since 1890.1
Active constituents: Cascara bark is high in
hydroxyanthraquinone glycosides called cascarosides. Resins, tannins, and lipids make up the
bulk of the other bark ingredients. Cascarosides have a cathartic action that induces the
large intestine to increase its muscular contraction (peristalsis), resulting in bowel
movement.2
How much is usually taken? Only the dried form of cascara
should be used. Capsules providing 20–30 mg of cascarosides per day can be used.
However, the smallest amount necessary to maintain soft stool should be used.3 As a
tincture, 1/4–1 teaspoon (1–5 ml) per day is generally taken. It is important to
drink eight 6-ounce (180 ml) glasses of water throughout the day while using cascara. Cascara
should be taken consecutively for no longer than eight to ten days.4
Are there any side effects or interactions? Women who are pregnant or breast-feeding, and children under the age of
12 should not use cascara without the advice of a physician. People with an intestinal
obstruction, Crohn’s disease, appendicitis or
abdominal pain should not employ this herb.5 Long-term use or abuse of cascara may
result in weakened bowel function. It may also cause a loss of electrolytes (especially the
mineral potassium). Loss of potassium can lead to
abnormalities of heart function and may augment the action of digitalis-like medications with
fatal consequences.
Are there any drug interactions? Certain medications may
interact with cascara. Refer to the drug interactions
safety check for a list of those medications.
References:
1. Castleman M. The Healing Herbs. Emmaus, PA: Rodale Press,
1991, 99–100.
2. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients
Used in Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
128–30.
3. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete
Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative
Medicine Communications, 1998, 104–5.
4. Bradley PR, ed. British Herbal Compendium, vol 1.
Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 52–4.
5. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete
Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative
Medicine Communications, 1998, 104–5.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|